Navigation Links
Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
Date:5/30/2012

ST. LOUIS, May 30, 2012 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced that William C. Mills III has been appointed as Chairman of its Board of Directors, effective immediately.  Mr. Mills has considerable experience serving on the boards of growing companies in the medical technology and biotechnology fields.  Mr. Mills replaces Fred A. Middleton, who will remain on the Board of Directors as an independent director.

Mr. Mills is currently an independent venture capitalist with over 30 years of experience in venture capital, and now serves as Chairman of the Board of Managers of Ascension Health Ventures III, LLC.   Since 1981, he has served in a partner role at Advent International, Ampersand Ventures, EGS Healthcare Capital Partners and The Venture Capital Fund of New England.  Mr. Mills has been a member of the Stereotaxis Board since June 2000 and has served as Chairman of the Company's Nominating and Corporate Governance Committee and the Strategy & Technology Committee.  Mr. Mills received his A.B. in Chemistry, cum laude, from Princeton University, his S.M. in Chemistry from the Massachusetts Institute of Technology and his M.S. in Management from MIT's Sloan School of Management.

"On behalf of the Board, I would like to extend our heartfelt gratitude to Fred for his over 20 years of service as Chairman and his many invaluable contributions to Stereotaxis," said William C. Mills III, Chairman of the Board of Directors.  "Fred has helped guide the Company through various business cycles with prudence and with our long-term strategy in mind.  We look forward to continuing to work with Fred and to his continued contributions."

"My decision to step down as Chairman of Stereotaxis will allow the Company to recruit new experienced talent at the Board leadership level.  I plan to devote more time
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Stereotaxis Announces Public Offering of Common Stock
4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Installs First System in Taiwan
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... ATLANTA , May 1, 2015 At ... May 2-6 in Washington D.C. , ... a solution that enables clinicians to leverage the enormous ... Knife radiosurgery treatments conducted each year – to advance ... "Gamma Knife Registry is a cloud-based solution that allows ...
(Date:5/1/2015)... May 1, 2015 The Institute for Healthcare ... literacy award winners. The IHA Health Literacy Awards aim ... impact on the practice of educating or empowering organizations ... gives awards in three categories: innovative programs, published materials ... Literacy Hero award. In the area of ...
(Date:5/1/2015)... MARLBOROUGH, Mass. , May 1, 2015  Boston ... overview of its continued business momentum and long-term growth ... in New York City . President ... outline the unique opportunities the company has to bring ... into fast growing markets and deliver shareholder value. ...
Breaking Medicine Technology:Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Institute for Healthcare Advancement Announces 2015 Award Winners 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7
... 2011 Reportlinker.com announces that ... is available in its catalogue: ... Drug Safety Strategies and Risk ... clinical success ...
... FRANCISCO, Calif., Oct. 26, 2011 Onyx Pharmaceuticals, ... results from a Bayer HealthCare Pharmaceuticals Phase 3 ... for the treatment of patients with metastatic colorectal ... standard therapies. The trial met its primary endpoint ...
Cached Medicine Technology:Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 2Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 3Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 4Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 5Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 6Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 7Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 8Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 2Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 3Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 4Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival 5
(Date:5/1/2015)... Ernst & Young (EY) has announced Melanie Rosenthal, ... and Burak Sezen, Co-Founder & CTO of RowdMap, Inc. ... The Year® 2015 Awards in the Ohio Valley Region ... leader in assurance, tax, transaction and advisory services and ... audit companies in the world. The awards program recognizes ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The Quail Creek ... American Cancer Society. Since 2001, the Quail Creek Relay team ... team host events throughout the year, including their biggest event, ... Golf Ball Drop. , Quail Creek Relay for Life ... battling cancer. Kate Kerwin, fitness director, states, “I was hooked ...
(Date:5/1/2015)... As the sale of legal, recreational cannabis in ... in the industry are looking back with some pride ... report by the ArcView Group , the legal ... nearly $3 billion in combined wholesale and retail sales. ... with the ongoing economic recovery, has led to a ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The frozen ... with the Hickory Crawdads (NC) and the Myrtle Beach ... have in-stadium concession locations and offer fans discounts at ... of the Hickory Community,” said Luke Shook, co-owner of ... great opportunity and we look forward to enjoying the ...
(Date:5/1/2015)... Pa. (PRWEB) May 01, 2015 Veteran Outreach ... be available to answer questions about VA Vet Centers on ... community. The MVC will be parked in front of the ... conjunction with a free screening of the documentary, “That Which ... impacts of post-traumatic stress disorder. , Please contact Robert Novotney ...
Breaking Medicine News(10 mins):Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... ... Feb. 3 The National Organization for Rare Disorders (NORD) ... will serve as media and program partners for Rare Disease Day on ... of Rare Disease Day, an event designed to call attention to the ...
... proposed by Max Kleiber in 1932, printed in biology textbooks ... in a 2000 essay in Nature as "extended to all ... wrong. "Actually, it,s two-thirds," says University of Vermont mathematician ... Physical Review Letters helps overturn almost eighty years ...
... , ... Hold Ribbon-Cutting Ceremony with Palms West Chamber of Commerce , ... (PRWEB) February 3, 2010 -- Hugs and Kisses, Inc. will be ... event kicks off with a ribbon-cutting ceremony by the Palms West Chamber of Commerce at 5:00 ...
... pedal-power brings results, study finds , WEDNESDAY, Feb. 3 (HealthDay News) ... who ride bicycles to school are in better shape than those ... of the study examined the results of physical tests and questionnaires ... in 2007 and 2008. , They found that boys who ...
... APR Energy is ... country of Haiti. The supplies will be delivered by four air- freighted shipments and are ... ... of the January 12 earthquake in Haiti, many corporations all over the world have been ...
... , , DUBLIN, Ohio , Feb. 3 ... approved a regular quarterly dividend of $0.175 per share, payable ... 1 . , This marks the 102nd consecutive regular quarterly dividend for ... Jan. 31 . , About Cardinal Health , ...
Cached Medicine News:Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 2Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 3Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 4Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 5Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 6Health News:Spherical cows help to dump metabolism law 2Health News:Spherical cows help to dump metabolism law 3Health News:Hugs and Kisses Open House To Mark The Opening Of Its New Facility 2Health News:APR Energy Launching Haiti Relief Efforts 2Health News:APR Energy Launching Haiti Relief Efforts 3Health News:APR Energy Launching Haiti Relief Efforts 4Health News:Cardinal Health Declares Regular Quarterly Dividend 2
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... in our largest chest freezer, with 20.7 ... 52,700 samples -- (572) 2" boxes. Like ... utilizes ultra-thin vacuum insulation panel technology to ... Patented Tollesbury Technology improves sample preservation, reduces ...
... III, laboratory-grade pure water at a constant ... potable tap water and combine complementary purification ... is easy to operate, reliable, and allows ... a low operating cost., Applications, Glassware ...
... Premium Model U570 is an ... standards as Innova models. Comparable in ... model uses conventional cascade refrigeration and ... price point. Holds 400 2" boxes. ...
Medicine Products: